SCHEMBL6711972

SCHEMBL6711972

COc1ccccc1-c1cccc2cc(C(=O)Nc3ccc(Cl)cc3-c3noc(=O)[nH]3)n(C)c12

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.43
GRIK1 P39086 1/20 0.40
MEN1 O00255 6/20 0.39
KMT2A Q03164 6/20 0.39
HPGD P15428 6/20 0.39
KDM4E B2RXH2 5/20 0.39
HSD17B10 Q99714 4/20 0.39
ALDH1A1 P00352 4/20 0.39
NPC1 O15118 3/20 0.39
POLB P06746 2/20 0.39
RAB9A P51151 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
TSHR P16473 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
ESR1 P03372 1/20 0.38
SCN10A Q9Y5Y9 1/20 0.37
CPT1A P50416 1/20 0.37
CPT1B Q92523 1/20 0.37
ROCK1 Q13464 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6708988 0.91 KDM4E (0.39) MAPTGRIK1MEN1KMT2AHPGD
SCHEMBL6710342 0.90 GRIK1 (0.42) GRIK1POLBROCK1
SCHEMBL6711901 0.89 GRIK1 (0.41) MAPTGRIK1MEN1KMT2ARAB9A
SCHEMBL6709192 0.89 GRIK1 (0.42) GRIK1ROCK1
SCHEMBL6708691 0.88 KDM4E (0.37) MAPTMEN1KMT2AHPGDKDM4E
SCHEMBL6709222 0.87 GRIK1 (0.40) GRIK1KMT2AKDM4ENPC1RAB9A
SCHEMBL6711990 0.87 GRIK1 (0.40) MAPTGRIK1CPT1ACPT1BROCK1
SCHEMBL6710353 0.86 GRIK1 (0.41) MAPTGRIK1MEN1KMT2AHPGD
SCHEMBL6713737 0.86 GRIK1 (0.44) MAPTGRIK1MEN1KMT2AHPGD
SCHEMBL6713393 0.85 GRIK1 (0.39) MAPTGRIK1HPGDALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 MAPT 4754/4885GRIK1 3885/4885MEN1 4100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.